Kidney Cancer
@KCA_Journal
Editors-in-Chief: Primo N. Lara Jr., MD, and Peter Mulders, MD | Dedicated to expediting our understanding & improving treatments of kidney cancer
ID:880866942416039936
http://www.journalkidneycancer.com 30-06-2017 19:13:39
724 Tweets
1,4K Followers
727 Following
Just in Kidney Cancer 👉Interesting study by #LunavandenBrink Patricia Zondervan comparing outcomes of radical vs. partial nephrectomy in pts w/ cT1b RCC #kidneycancer 👉10-year survival rates were similar between both groups👇
tinyurl.com/bdzm9b5b UroToday.com OncoAlert KidneyCAN
Just in Kidney Cancer 👉Excellent review by #AlbertLee James Yu on the role of radiation therapy (SBRT) in the Rx of localized and oligometastatic RCC #kidneycancer 👉SBRT use will likely increase in the future 👇👇
tinyurl.com/y3upcu8m UroToday.com OncoAlert KidneyCAN
Just in Kidney Cancer 👉Excellent review by #MartaAmannArévalo Javier Puente on different molecularly defined RCC #kidneycancer & their Rx 👉further research is needed to identify beneficial therapies in these subgroups 👇👇
tinyurl.com/bp632yzb UroToday.com OncoAlert KidneyCAN
Just in Kidney Cancer 👉Insightful commentary by Shuchi Gulati MD @primolaraMD on recent LITESPARK-005 data from #ESMO23 in advanced ccRCC #kidneycancer 👉belzutifan showed improved PFS & QoL outcomes over everolimus👇👇 tinyurl.com/37zyyee9 OncoAlert UroToday.com KidneyCAN
Just in Kidney Cancer 👉Excellent review by drfrankiejs Tom Powles on adjuvant Rx in RCC #kidneycancer 👉w/ the +ve results of KEYNOTE-564, biomarkers are needed to identify pts who may benefit from adj Rx👇👇
tinyurl.com/y6w52prn Uromigos OncoAlert KidneyCAN Kidney Cancer
Grateful for the opportunity to discuss advances in bladder, prostate, and kidney cancers with the incredible Rana McKay and Neeraj Agarwal, MD, FASCO what a time for urologic oncology! University of Utah Urology Huntsman Cancer Institute Society of Urologic Oncology YUO
Just in Kidney Cancer 👉Excellent systematic review by Eric Jonasch on different Rx modalities for VHL-associated RCC #kidneycancer 👉Responses were observed w/ systemic Rx, including belzutifan, warranting additional studies👉tinyurl.com/5xh9w9bc OncoAlert UroToday.com KidneyCAN
Just in 👉Full length #GU24 ASCO abstracts are now available online (except LBAs). Here is the weblink👉 tinyurl.com/3eearrj9 UroToday.com OncoAlert Uromigos PCF Science Bladder Cancer Advocacy Network KidneyCAN Kidney Cancer #ASCODailyNews
Just in Kidney Cancer👉Excellent review on emerging ADCs in mRCC #KidneyCancer 👉several potential targets were identified, and many promising candidates are currently under investigation👇👇tinyurl.com/mrydnwdp @HCGottlich Reza Nabavizadeh, MD Fabrice Lucien, PhD OncoAlert UroToday.com KidneyCAN
Just In Kidney Cancer: Real-world study shows tumor-specific gene expression by RNA sequencing could serve as a potential biomarker of response to ipi + nivo Rx for mRCC #kidneycancer @tripNish Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO👉tinyurl.com/mr3xfutf OncoAlert KidneyCAN UroToday.com
Recently in Kidney Cancer 👉Interesting real-world study on #Axitinib as 2L Rx or beyond of advanced/metastatic #RCC in the STAR-TOR registry 👉⬆️LDH could be a⛔️predictive marker for #Axitinib effectiveness👉tinyurl.com/mrx74xkn OncoAlert UroToday.com Annemarie Uhlig #ArneStrauß
Recently In Kidney Cancer 👉Remarkable review on adjuvant Rx in localized or locoregional #RCC 👉w/ sunitinib improving DFS, and recent data showing improved OS w/ pembro, Rx options in this setting are ⬆️👉tinyurl.com/4euc6yw2 OncoAlert UroToday.com #LukeWang Rana McKay
The Kidney Cancer Journal is the proud media partner of the IKCS 2023.
View the program and speakers at 👉 bit.ly/IKCSNA23
#Kidneycancer #IKCSNA23
Kidney Cancer
The Kidney Cancer Association is the proud media partner of the IKCS 2023.
View the program and speakers at 👉 bit.ly/IKCSNA23
#Kidneycancer #IKCSNA23
Kidney Cancer
Recently In Kidney Cancer 👉Excellent Review by Nicholas Schindler David Braun on tumor antigen targets in ccRCC👉tinyurl.com/3wvym7se👉A concerted effort for antigen discovery is needed to design future precision antigen-directed IO OncoAlert Kidney Cancer UroToday.com
Just In Kidney Cancer👉Remarkable Review by James Brundage Benjamin L Maughan on the efficacy of MET inhibitors in pts with papillary RCC 👉tinyurl.com/44dkmddz 👉Cabozantinib has the best evidence for use as 1L Rx OncoAlert Kidney Cancer UroToday.com
Just in JAMA Oncology @jamaonc 👉Serum CRP & albumin as potential on-treatment biomarkers for tailoring treatment in mRCC #kidneycancer Editorial by our star fellows Georges Gebrael Gliceida Galarza, MD Full paper👉 tinyurl.com/3dhkjt9d GU Cancer Research Program @HuntsmanCancer Kidney Cancer UroToday.com OncoAlert